Antenatal perspective of hypoplastic left heart syndrome: 5 years on

S V Rasiah1, A K Ewer, P Miller

  • 1Department of Neonatology, Birmingham Women's Hospital NHS Trust, Edgbaston, Birmingham B15 2TG, UK.

Insights

Outcomes for babies with hypoplastic left heart syndrome (HLHS) improved, with fewer parents choosing termination after antenatal diagnosis. However, overall survival remains a concern for HLHS patients diagnosed in utero.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Neonatal Surgery

Background:

  • Palliative staged reconstructive surgery has significantly improved outcomes for infants with hypoplastic left heart syndrome (HLHS).
  • Refined cardiothoracic and intensive care techniques have further advanced treatment protocols for HLHS.

Purpose of the Study:

  • To compare the outcomes of antenatally diagnosed HLHS cases with a cohort from five years prior.
  • To evaluate the impact of improved surgical and intensive care techniques on HLHS patient survival.

Main Methods:

  • A comparative analysis of HLHS cases diagnosed antenatally between January 2000 and December 2004.
  • Inclusion of all identified HLHS cases, tracking pregnancy terminations, stillbirths, and postnatal outcomes.

Main Results:

  • Pregnancy termination rates decreased from 43.7% to 25.3% after antenatal HLHS diagnosis.
  • Early surgical mortality after the Norwood procedure was 19.4%, with 20 patients surviving.
  • Overall intention-to-treat survival for HLHS was 46.9% (23/49).

Conclusions:

  • The reduction in pregnancy terminations for HLHS signifies improved parental decision-making support.
  • Despite advances in surgical survival post-Norwood procedure, overall survival for antenatally diagnosed HLHS remains suboptimal.
  • Congenital malformations diagnosed prenatally, such as HLHS, continue to present poorer outcomes compared to postnatal diagnoses.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...